Percutaneous vertebroplasty in 1,253 levels: results and long-term effectiveness in a single centre.

Autor: Masala S, Mastrangeli R, Petrella MC, Massari F, Ursone A, Simonetti G, Masala, Salvatore, Mastrangeli, Roberta, Petrella, Maria Chiara, Massari, Francesco, Ursone, Antonio, Simonetti, Giovanni

Publikováno v: European Radiology; Jan2009, Vol. 19 Issue 1, p165-171, 7p

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.

Autor: Tuninetti V; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy. Electronic address: dr.ssatuninettivalentina@gmail.com., Virano E; Department of Oncology, University of Turin, 10124 Turin, Italy., Salutari V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Ricotti A; Clinical Trial, Ordine Mauriziano Hospital, 10128 Turin, Italy., Pisano C; Dipartimento Uro-Ginecologico, Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Naples, Italy., Ducceschi M; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Turitto G; Division of Oncology, AORN 'Sant' Anna e San Sebastiano', Caserta, Italy., Scandurra G; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy., Petrella MC; Oncologia Medica Ginecologica, Azienda Universitaria Ospedaliera Careggi, Firenze, Italy., Forestieri V; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy., Rizzetto M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy., Mammoliti S; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Artioli G; Ulss2 Oncologia Medica Marca Trevigiana, Treviso, Italy., Cioffi R; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy., Borsotti L; Clinical Trial, Ordine Mauriziano Hospital, 10128 Turin, Italy., Bellero M; SC Farmacia Ospedaliera, Ordine Mauriziano Hospital, 10028 Turin, Italy., Rognone C; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy., Carbone V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Ferrandina G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Mantiero M; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Azzolina C; SC Direzione Sanitaria, Ordine Mauriziano Hospital, 10028 Turin, Italy., Geninatti E; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy., Pignata S; Dipartimento Uro-Ginecologico, Istituto Nazionale Tumori di Napoli Fondazione G Pascale IRCCS, Naples, Italy., Valabrega G; Department of Oncology, University of Turin, Medical Oncology, Ordine Mauriziano Hospital, Italy.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 203, pp. 114039. Date of Electronic Publication: 2024 Mar 30.

Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.

Autor: Colombo N; Gynecologic Oncology Program, European Institute of Oncology, IRCSS, Milano, Italy; Department of Medicine and Surgery, University of Milano Bicocca, Milano, Italy., Gadducci A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy., Landoni F; Department of Obstetrics and Gynecology, San Gerardo Hospital and University of Milano Bicocca, Milano, Italy., Lorusso D; Fondazione Policlinico Gemelli IRCSS and Università Cattolica del Sacro Cuore, Roma, Italy. Electronic address: domenica.lorusso@policlinicogemelli.it., Sabbatini R; Medical Oncology Division, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy., Artioli G; Ulss2 Oncologia Medica Marca Trevigiana, Treviso, Italy., Berardi R; Department of Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Ceccherini R; Department of Oncology, Azienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste, Italy., Cecere SC; U.O.C. of Experimental Uro-Gynecological Clinical Oncology, Istituto Nazionale Tumori, IRCSS, Fondazione G. Pascale, Napoli, Italy., Cormio G; Ginecologic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Italy; Department of Interdisciplinary Medicine (DIM), University of Bari, 70121 Bari, Italy., De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Legge F; Gynecologic Oncology Unit, General Regional Hospital 'F. Miulli' of Acquaviva delle Fonti, Italy., Lissoni A; Department of Medicine and Surgery, Clinic of Obstetrics and Gynecology, San Gerardo Hospital, Monza, University of Milan Bicocca, Milan, Italy., Mammoliti S; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Mangili G; Gynecology/Obstetrics Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Naglieri E; Department of Medical Oncology, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari 70124, Italy., Petrella MC; Oncologia Medica Ginecologica, Azienda Universitaria Ospedaliera Careggi, Firenze, Italy., Ricciardi GRR; Medical Oncology Unit, Papardo Hospital, Messina, Italy., Ronzino G; Department of Oncology, Ospedale 'Vito Fazzi', Lecce, Italy., Salutari V; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy., Sambataro D; Oncologia Medica, Ospedale Umberto I ASP, Enna, Italy., Savarese A; Division of Medical Oncology 1, IRCCS - Regina Elena National Cancer Institute, Rome, Italy., Scandurra G; Medical Oncology Unit, Cannizzaro Hospital, Catania, Italy., Tasca G; Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy., Tomao F; Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy., Valabrega G; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, 10128 Turin, Italy., Zavallone L; Department Medical Oncology, Infermi Hospital, Biella, Italy., Pignata S; U.O.C. of Experimental Uro-Gynecological Clinical Oncology, Istituto Nazionale Tumori, IRCSS, Fondazione G. Pascale, Napoli, Italy.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2023 Aug; Vol. 175, pp. 182-189. Date of Electronic Publication: 2023 Jun 22.

Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment.

Autor: Gambale E; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy., Fancelli S; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy., Caliman E; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Petrella MC; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy., Doni L; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy., Pillozzi S; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy., Antonuzzo L; Clinical Oncology Unit, University Hospital Careggi, Firenze, Italy lorenzo.antonuzzo@unifi.it.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).

Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes.

Autor: Gensini F; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Sestini R; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., De Luca A; Medical Genetics Division, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013, San Giovanni Rotondo, FG, Italy., Pinna V; Medical Genetics Division, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013, San Giovanni Rotondo, FG, Italy., Daniele P; Medical Genetics Division, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013, San Giovanni Rotondo, FG, Italy., Orzalesi L; Department of Experimental and Clinical Medicine, University of Florence, 50134, Florence, Italy., Petrella MC; Medical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Porfirio B; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Papi L; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Viale Pieraccini 6, 50139, Florence, Italy. laura.papi@unifi.it.

Publikováno v: Familial cancer [Fam Cancer] 2021 Jul; Vol. 20 (3), pp. 195-199. Date of Electronic Publication: 2020 Nov 19.